Accretion Pharmaceuticals Limited
ListedSMEHealthcare / Pharma · NSE
Accretion Pharmaceuticals Limited, founded in 2012 and based in Ahmedabad-Sanand, Gujarat, is a pharmaceutical company active in formulations and contract manufacturing with 83 employees as of January 2025. The company offers a wide range of products including tablets, capsules, syrups, ointments, creams, medicated shampoos, dusting powders, and ayurvedic wellness products, and also provides third-party manufacturing services. The proposed fund usage mainly focuses on growth capex such as facility upgrades and new machinery to increase capacity and support exports to 20+ countries, along with working capital needs, limited debt repayment, and flexibility for general purposes, helping the company scale operations, maintain quality standards, improve liquidity, and support future expansion opportunities.
Price Band
₹101
Issue Size
₹29.75 Cr
Lot Size
1200 shares
GMP
—
Est. Listing
₹101
at current GMP
Subscribed
7.32x
overall
Open
14 May 2025
Close
16 May 2025
Allotment
19 May 2025
Refund
20 May 2025
Demat Credit
21 May 2025
Listing
21 May 2025
Last updated 12 days ago
Official Registrar Verification
Accretion Pharmaceuticals Limited Allotment Status
Designated Registrar: Kfin Technologies Limited
Allotment Date
19 May 2025
Basis finalization
Refunds Initiate
20 May 2025
Mandate release
Demat Credit
21 May 2025
Shares in demat
Listing Debut
21 May 2025
Trading begins
How to Check Accretion Pharmaceuticals Limited IPO Allotment Status
- Click the Check on Registrar button above to visit Kfin Technologies Limited's allotment portal.
- Select Accretion Pharmaceuticals Limited from the dropdown company list.
- Choose your lookup mode: PAN Number, Application Number, or DP Client ID.
- Enter your details accurately and solve the Captcha code.
- Click Submit / Search to view the number of shares applied and allotted to you.
About Accretion Pharmaceuticals Limited Public Issue & Market Profile
Accretion Pharmaceuticals Limited is bringing an initial public offering (IPO) in the Healthcare / Pharma sector with an aggregate issue size of ₹29.75 Crores. The shares are offered at a price band of ₹101 to ₹101 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Public Issue & Allotment Procedure:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1200 shares (approx. ₹1,21,200 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Official Allotment Timelines & Registrar Guidance:
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-05-21, while un-allotted funds or UPI block mandates will be released on 2025-05-20.
Frequently Asked Questions
What if my name is not showing on the registrar portal?
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
How will I receive the refund if I don't get allotment?
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.